IntriCon Corporation
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Mark Gorder
- Full Time Employees
- 873
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 1260 Red Fox Road Arden Hills MN United States of America 55112
- IPO Date
- Mar 17, 1980
- CIK
- 0000088790
- Website
- intricon.com
- Similar Companies
- Business
- IntriCon Corporation IntriCon Corporation (NASDAQ:IIN) serves as a contract development and manufacturing organization (CDMO) focused exclusively on micromedical devices, designing, developing, engineering, manufacturing, and packaging high-precision components, subassemblies, and final products for medical device original equipment manufacturers (OEMs); its core offerings encompass precision molding including needle and insert molding, microelectronics assembly with ultra-fine pitch circuits down to 01005 components, custom electromagnetic sensors and assemblies, microcatheters and access sheaths, polymer and metal 3D printing, automation integration, and finished device packaging with automated vision inspection. The company targets high-growth medical markets such as diabetes management, neuromodulation, cardiology, orthopedics, peripheral vascular, interventional pulmonology, electrophysiology, advanced optics, surgical energy, vascular disease, drug delivery, and surgical navigation, serving customers including OEMs, startups, and research institutions with scalable production from prototypes to tens of millions of units annually. Founded in 1977 and headquartered in Arden Hills, Minnesota, with previous facilities in the United States (Minnesota, Illinois, California), Singapore, Indonesia, and Germany, IntriCon operates globally across four countries and maintains ISO 13485 certification and FDA registration, producing over 250 million components and assemblies per year with more than 1,000 employees. In recent major developments, Altaris Capital Partners acquired IntriCon in 2022 for $24.25 per share in a $241 million equity transaction, marking its transition to private ownership; in September 2024, the company divested its Hearing Health business to Huizhou Jinghao Medical Technology Co., Ltd., sharpening its 100% focus on non-hearing micromedical solutions; and in October 2025, IntriCon combined with Minnetronix Medical to form Forj Medical, a vertically integrated CDMO headquartered in Arden Hills, Minnesota, with expanded operations across six facilities in the United States, Indonesia, Singapore, and Costa Rica, enhancing end-to-end capabilities in system design, microelectronics, precision molding, and advanced manufacturing.
Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates OBNK, IIN, Y, VEC
TTDKY vs. IIN: Which Stock Should Value Investors Buy Now?
INTRICON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intricon Corporation - IIN
INTRICON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intricon Corporation - IIN
Stocks To Invest In Right Now? 5 Health Care Stocks For Your March Watchlist
IntriCon Corporation (IIN) Stock: Why It Surged Today
SHAREHOLDER ALERT: WeissLaw LLP Investigates IntriCon Corporation
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Intricon Corporation Buyout
Why Are Intricon Shares Surging Monday
Shareholder Alert: Ademi LLP investigates whether Intricon Corporation has obtained a Fair Price in its transaction with Altaris.
IIN Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of IntriCon Corporation Is Fair to Shareholders
IIN Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of IntriCon Corporation Is Fair to Shareholders
Intricon Reports Fourth Quarter and Full Year 2021 Results
Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million
TTDKY vs. IIN: Which Stock Is the Better Value Option?
IntriCon Corporation (IIN) CEO Scott Longval on Q3 2021 Results - Earnings Call Transcript
IntriCon Corporation (IIN) Beats Q3 Earnings Estimates
Intricon Reports Third Quarter 2021 Results
Intricon Announces CFO Departure and Preliminary Third Quarter 2021 Revenue